252 related articles for article (PubMed ID: 26912188)
1. Self-assembled drug delivery system based on low-molecular-weight bis-amide organogelator: synthesis, properties and in vivo evaluation.
Li Z; Cao J; Li H; Liu H; Han F; Liu Z; Tong C; Li S
Drug Deliv; 2016 Oct; 23(8):3168-3178. PubMed ID: 26912188
[TBL] [Abstract][Full Text] [Related]
2. Parenteral thermo-sensitive organogel for schizophrenia therapy, in vitro and in vivo evaluation.
Wang D; Zhao J; Liu X; Sun F; Zhou Y; Teng L; Li Y
Eur J Pharm Sci; 2014 Aug; 60():40-8. PubMed ID: 24815944
[TBL] [Abstract][Full Text] [Related]
3. Studies on the in vitro and in vivo degradation behavior of amino acid derivative-based organogels.
Li Z; Cao J; Hu B; Li H; Liu H; Han F; Liu Z; Tong C; Li S
Drug Dev Ind Pharm; 2016 Nov; 42(11):1732-41. PubMed ID: 27018332
[TBL] [Abstract][Full Text] [Related]
4. Organogels based on amino acid derivatives and their optimization for drug release using response surface methodology.
Hu B; Yan H; Sun Y; Chen X; Sun Y; Li S; Jing Y; Li H
Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):266-275. PubMed ID: 31851842
[TBL] [Abstract][Full Text] [Related]
5. Preparation and characterization of 12-HSA-based organogels as injectable implants for the controlled delivery of hydrophilic and lipophilic therapeutic agents.
Esposito CL; Tardif V; Sarrazin M; Kirilov P; Roullin VG
Mater Sci Eng C Mater Biol Appl; 2020 Sep; 114():110999. PubMed ID: 32993979
[TBL] [Abstract][Full Text] [Related]
6. Formulation and evaluation of novel controlled release of topical pluronic lecithin organogel of mefenamic acid.
Jhawat V; Gupta S; Saini V
Drug Deliv; 2016 Nov; 23(9):3573-3581. PubMed ID: 27494650
[TBL] [Abstract][Full Text] [Related]
7. Factors influencing the erosion rate and the drug release kinetics from organogels designed as matrices for oral controlled release of a hydrophobic drug.
Pereira Camelo SR; Franceschi S; Perez E; Girod Fullana S; Ré MI
Drug Dev Ind Pharm; 2016; 42(6):985-97. PubMed ID: 26548427
[TBL] [Abstract][Full Text] [Related]
8. Self-assembled L-alanine derivative organogel as in situ drug delivery implant: characterization, biodegradability, and biocompatibility.
Wang K; Jia Q; Han F; Liu H; Li S
Drug Dev Ind Pharm; 2010 Dec; 36(12):1511-21. PubMed ID: 21050137
[TBL] [Abstract][Full Text] [Related]
9. Characterization of organogel as a novel oral controlled release formulation for lipophilic compounds.
Iwanaga K; Sumizawa T; Miyazaki M; Kakemi M
Int J Pharm; 2010 Mar; 388(1-2):123-8. PubMed ID: 20045041
[TBL] [Abstract][Full Text] [Related]
10. In situ-forming pharmaceutical organogels based on the self-assembly of L-alanine derivatives.
Couffin-Hoarau AC; Motulsky A; Delmas P; Leroux JC
Pharm Res; 2004 Mar; 21(3):454-7. PubMed ID: 15070096
[TBL] [Abstract][Full Text] [Related]
11. A novel flunarizine hydrochloride-loaded organogel for intraocular drug delivery in situ: Design, physicochemical characteristics and inspection.
Dai M; Bai L; Zhang H; Ma Q; Luo R; Lei F; Fei Q; He N
Int J Pharm; 2020 Feb; 576():119027. PubMed ID: 31953090
[TBL] [Abstract][Full Text] [Related]
12. Formulation and evaluation of lecithin organogel for topical delivery of fluconazole.
Jadhav KR; Kadam VJ; Pisal SS
Curr Drug Deliv; 2009 Apr; 6(2):174-83. PubMed ID: 19450224
[TBL] [Abstract][Full Text] [Related]
13. Degradation of glutamate-based organogels for biodegradable implants: In vitro study and in vivo observation.
Hu B; Wang W; Wang Y; Yang Y; Xu L; Li S
Mater Sci Eng C Mater Biol Appl; 2018 Jan; 82():80-90. PubMed ID: 29025677
[TBL] [Abstract][Full Text] [Related]
14. Combined effect of shearing and cooling rate on the rheology of organogels developed by selected gelators.
De la Peña-Gil A; Álvarez-Mitre FM; González-Chávez MM; Charó-Alonso MA; Toro-Vazquez JF
Food Res Int; 2017 Mar; 93():52-65. PubMed ID: 28290280
[TBL] [Abstract][Full Text] [Related]
15. Improved initial burst of estradiol organogel as long-term in situ drug delivery implant: formulation, in vitro and in vivo characterization.
Yang Y; Xu L; Gao Y; Wang Q; Che X; Li S
Drug Dev Ind Pharm; 2012 May; 38(5):550-6. PubMed ID: 22420863
[TBL] [Abstract][Full Text] [Related]
16. Sodium alginate in oil-poloxamer organogels for intravaginal drug delivery: Influence on structural parameters, drug release mechanisms, cytotoxicity and in vitro antifungal activity.
Querobino SM; de Faria NC; Vigato AA; da Silva BGM; Machado IP; Costa MS; Costa FN; de Araujo DR; Alberto-Silva C
Mater Sci Eng C Mater Biol Appl; 2019 Jun; 99():1350-1361. PubMed ID: 30889669
[TBL] [Abstract][Full Text] [Related]
17. Characterization of gelation process and drug release profile of thermosensitive liquid lecithin/poloxamer 407 based gels as carriers for percutaneous delivery of ibuprofen.
Djekic L; Krajisnik D; Martinovic M; Djordjevic D; Primorac M
Int J Pharm; 2015 Jul; 490(1-2):180-9. PubMed ID: 26002567
[TBL] [Abstract][Full Text] [Related]
18. Systematic modifications of amino acid-based organogelators for the investigation of structure-property correlations in drug delivery system.
Hu B; Sun W; Li H; Sui H; Li S
Int J Pharm; 2018 Aug; 547(1-2):637-647. PubMed ID: 29933060
[TBL] [Abstract][Full Text] [Related]
19. Release Characteristics In Vitro and In Vivo of In Situ Gels for a Novel Peptide Compared with Low-Molecular-Weight Hydrophilic Drug.
Zhang G; Hu J; Meng Q; Wang T; Yang X; Gao L; Quan D
Curr Drug Deliv; 2017; 14(1):47-53. PubMed ID: 27440072
[TBL] [Abstract][Full Text] [Related]
20. Oral liquid in situ gelling methylcellulose/alginate formulations for sustained drug delivery to dysphagic patients.
Shimoyama T; Itoh K; Kobayashi M; Miyazaki S; D'Emanuele A; Attwood D
Drug Dev Ind Pharm; 2012 Aug; 38(8):952-60. PubMed ID: 22283456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
